獣医オンコロジーの世界市場レポート 2024

獣医オンコロジーの市場規模は、今後数年間で急速に成長すると予想されます。 2028年には11.2%の年間平均成長率（CAGR）で6億2,000万米ドルに成長すると予想されます。予測期間に予想される成長は、動物に合わせた個別化医療の出現、動物集団におけるがんの有病率の増加、専門的なケアを必要とする高齢のペット人口の増加、専門医療へのアクセスの改善、獣医療サービス、および現場での支援的な規制措置と承認など、いくつかの要因によって推進されると予想されます。

ペットのがん症例の急増は、獣医オンコロジー市場の成長を促進すると予想されます。腫瘍形成につながる不規則な細胞増殖を特徴とするこの状態は、動物の診断と治療を行い、病気の進行を抑えるための獣医オンコロジーの集中的な取り組みを促しています。注目すべきことに、全米犬がん財団のデータによると、2021年の純血種の犬のがんによる死亡率は憂慮すべき25%であり、10歳以上の犬がこの病気にかかる可能性は45%に達していることが明らかになった。国立医学図書館のさらなる統計では、同じ期間に米国の犬人口9,000万頭のうち、がんと診断された犬の数が400万から600万匹に上ることが示されており、ペットがんの発生率の増加が獣医オンコロジーサービスの需要を促進していることが示されています。

ペットの養子縁組の増加により、獣医オンコロジーセクターが推進されると予想されます。ペットの養子縁組には、世話や交流の提供が含まれており、ペットの健康に対する一層の取り組みを強調しています。この取り組みに動かされて、ペットの飼い主は、がんの診断や治療を含む予防ヘルスケアや医療介入への強い傾向を示しています。米国ペット製品協会が主催する全米ペット所有者調査が実施した最近の調査では、米国の世帯の約67％がペットを飼っており、犬が好ましい選択肢として浮上していることが明らかになった。この傾向は、ペットの普及の増加によって獣医オンコロジーの市場が成長していることを示しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の獣医オンコロジー市場、治療別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 手術
• 放射線科
• 化学療法
• その他
• 世界の獣医オンコロジー市場、動物タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 馬
• 犬
• ネコ
• その他
• 世界の獣医オンコロジー市場、がんタイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• リンパ腫
• 肥満細胞がん
• 乳腺がんおよび扁平上皮がん
• その他

第7章 地域および国の分析

• 世界の獣医オンコロジー市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界の獣医オンコロジー市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 獣医オンコロジー市場の競合情勢
• 獣医オンコロジー市場の企業プロファイル
  • PetCure Oncology Inc.
  • Zoetis Inc.
  • Karyopharm Therapeutics Inc.
  • Varian Medical Systems Inc.
  • Accuray Incorporated

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

Veterinary oncology involves the specialized diagnosis and treatment of cancer in animals, aiming to integrate cancer therapies while maintaining the overall quality of life for the affected animals. This field focuses on providing cancer medicine and treatment services tailored to the unique needs of animals.

The primary types of therapies in veterinary oncology include surgery, radiology, chemotherapy, and other specialized treatments. Surgery involves procedures to either remove or repair affected body parts or to assess the presence of disease. A diverse range of animals, including equines, canines, felines, and other species, are involved in veterinary oncology. The field encompasses various cancer types such as lymphomas, mast cell cancer, mammary cancer, squamous cell cancer, among others, specific to different animal species.

The veterinary oncology market research report is one of a series of new reports from The Business Research Company that provides veterinary oncology market statistics, including veterinary oncology industry global market size, regional shares, competitors with veterinary oncology market share, detailed veterinary oncology market segments, market trends, and opportunities, and any further data you may need to thrive in the veterinary oncology industry. This veterinary oncology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The veterinary oncology market size has grown rapidly in recent years. It will grow from $0.36 billion in 2023 to $0.4 billion in 2024 at a compound annual growth rate (CAGR) of 12.5%. The growth observed in the historic period can be attributed to several factors, including the rise in pet ownership, the trend of humanizing pets which leads to increased care standards, knowledge transfer from advancements in human oncology to veterinary practices, a growing awareness regarding pet health, and advancements in pharmaceuticals tailored for veterinary use.

The veterinary oncology market size is expected to see rapidly grown in the next few years. It will grow to $0.62 billion in 2028 at a compound annual growth rate (CAGR) of 11.2%. The anticipated growth in the forecast period is expected to be driven by several factors, including the emergence of personalized medicine tailored for animals, an increasing prevalence of cancer in animal populations, the growth of the geriatric pet population requiring specialized care, improved access to specialized veterinary services, and supportive regulatory measures and approvals in the field.

The surge in pet cancer cases is set to drive growth in the veterinary oncology market. The condition, marked by irregular cell growth leading to tumor formation, has prompted focused efforts in veterinary oncology to diagnose and treat animals, curtailing disease progression. Notably, data from the National Canine Cancer Foundation revealed a concerning 25% mortality rate among purebred dogs due to cancer in 2021, with those aged ten or older facing a 45% likelihood of contracting the disease. Further statistics from the National Library of Medicine showcased a significant 4-6 million dogs diagnosed with cancer among the 90 million dog population in the US during the same period, indicating the rising incidence of pet cancer driving the demand for veterinary oncology services.

The uptick in pet adoption is anticipated to propel the veterinary oncology sector. Pet adoption, encompassing the provision of care and companionship, underscores a heightened commitment to pet well-being. Driven by this commitment, pet owners exhibit a stronger inclination towards preventive healthcare and medical interventions, including cancer diagnostics and therapies. Recent surveys conducted by the National Pet Owners Survey, facilitated by the American Pet Products Association, revealed that approximately 67% of US households are pet owners, with dogs emerging as the preferred choice. This trend signifies a growing market for veterinary oncology fueled by the increasing adoption of pets.

Innovation remains a cornerstone trend shaping the landscape of veterinary oncology. Leading companies in this sector are actively dedicated to pioneering novel solutions to fortify their market position. Notable among these advancements is the launch of 'OncoK9' by PetDx in June 2021. This groundbreaking multi-cancer early detection test harnesses genomic prowess to facilitate the early detection of cancer in dogs through routine blood draws. Offering accurate canine cell-free DNA analysis, this test delivers digital reports with high diagnostic precision and minimal false-positive rates, enhancing early cancer diagnosis in canines.

Major players are strategically forging partnerships and collaborations with startups and mid-sized entities in the veterinary oncology market to diversify their offerings. These alliances serve as catalysts for portfolio expansion and geographical outreach. A pertinent example is the strategic partnership between Thrive Pet Healthcare and FidoCure initiated in June 2022. This collaboration endeavors to redefine veterinary cancer care by leveraging FidoCure's cutting-edge precision medicine platform and diagnostic algorithms across Thrive Pet Healthcare's extensive network of over 350 veterinary care clinics, aiming to enhance outcomes for pets diagnosed with cancer.

In July 2022, Zomedica Corp., a veterinary health company based in the US specializing in diagnostic and therapeutic products, completed the acquisition of Assisi Animal Health LLC for an undisclosed sum. This strategic acquisition aims to synergize resources between Zomedica and Assisi, empowering Zomedica to fortify and broaden its product offerings, ultimately providing advanced solutions to elevate companion animal care. Assisi Animal Health LLC, also based in the US, focuses on offering drug-free devices utilizing targeted pulsed electromagnetic field (tPEMF) technology, specifically used for reducing inflammation and treating cancer in dogs.

Major companies operating in the veterinary oncology market report are PetCure Oncology Inc., Zoetis Inc., Karyopharm Therapeutics Inc., Varian Medical Systems Inc., Accuray Incorporated, Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., One Health Company Inc., Regeneus Limited, VetDC Inc., Pharmaust Limited, AdvaVet Inc., Nippon Zenyaku Kogyo Company Limited, Rhizen Pharmaceutical SA, AB Science SAS, Siemens Healthineers AG Varian Medical Systems, Pfizer Inc., Takis Biotech GmbH, Qbiotics LLC, Jaguar Animal Health Solutions Inc., Orion Corporation A/B, Invectys S.A., Virbac SA, SeQuent Scientific Limited, Ceva Sante Animale S.A., Vetoquinol S.A., IDVet Inc., Bayer Aktiengesellschaft, Morphogenesis Inc., ZENOAQ GmbH, Oncovet Clinical Research Inc. .

Asia-Pacific was the largest region in the veterinary oncology market in 2023. North America is expected to be the fastest-growing region in the veterinary oncology market report during the forecast period. The regions covered in the veterinary oncology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the veterinary oncology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The veterinary oncology market includes revenues earned by entities by providing cryosurgery, comprehensive care, immunotherapy, and palliative care. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Oncology Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary oncology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary oncology? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The veterinary oncology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Therapy: Surgery; Radiology; Chemotherapy; Other Therapies
• 2) By Animal Type: Equine; Canine; Feline; Other Animal Types
• 3) By Cancer Type: Lymphoma; Mast Cell Cancer; Mammary And Squamous Cell Cancer; Other Cancer Types
• Companies Mentioned: PetCure Oncology Inc.; Zoetis Inc.; Karyopharm Therapeutics Inc.; Varian Medical Systems Inc.; Accuray Incorporated
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Veterinary Oncology Market Characteristics

3. Veterinary Oncology Market Trends And Strategies

4. Veterinary Oncology Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Veterinary Oncology Market Size and Growth

• 5.1. Global Veterinary Oncology Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Veterinary Oncology Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Veterinary Oncology Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Veterinary Oncology Market Segmentation

• 6.1. Global Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Surgery
• Radiology
• Chemotherapy
• Other Therapies
• 6.2. Global Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Equine
• Canine
• Feline
• Other Animal Types
• 6.3. Global Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Lymphoma
• Mast Cell Cancer
• Mammary And Squamous Cell Cancer
• Other Cancer Types

7. Veterinary Oncology Market Regional And Country Analysis

• 7.1. Global Veterinary Oncology Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Veterinary Oncology Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Veterinary Oncology Market

• 8.1. Asia-Pacific Veterinary Oncology Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Veterinary Oncology Market

• 9.1. China Veterinary Oncology Market Overview
• 9.2. China Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Veterinary Oncology Market

• 10.1. India Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Veterinary Oncology Market

• 11.1. Japan Veterinary Oncology Market Overview
• 11.2. Japan Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Veterinary Oncology Market

• 12.1. Australia Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Veterinary Oncology Market

• 13.1. Indonesia Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Veterinary Oncology Market

• 14.1. South Korea Veterinary Oncology Market Overview
• 14.2. South Korea Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Veterinary Oncology Market

• 15.1. Western Europe Veterinary Oncology Market Overview
• 15.2. Western Europe Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Veterinary Oncology Market

• 16.1. UK Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Veterinary Oncology Market

• 17.1. Germany Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Veterinary Oncology Market

• 18.1. France Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Veterinary Oncology Market

• 19.1. Italy Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Veterinary Oncology Market

• 20.1. Spain Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Veterinary Oncology Market

• 21.1. Eastern Europe Veterinary Oncology Market Overview
• 21.2. Eastern Europe Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Veterinary Oncology Market

• 22.1. Russia Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Veterinary Oncology Market

• 23.1. North America Veterinary Oncology Market Overview
• 23.2. North America Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Veterinary Oncology Market

• 24.1. USA Veterinary Oncology Market Overview
• 24.2. USA Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Veterinary Oncology Market

• 25.1. Canada Veterinary Oncology Market Overview
• 25.2. Canada Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Veterinary Oncology Market

• 26.1. South America Veterinary Oncology Market Overview
• 26.2. South America Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Veterinary Oncology Market

• 27.1. Brazil Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Veterinary Oncology Market

• 28.1. Middle East Veterinary Oncology Market Overview
• 28.2. Middle East Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Veterinary Oncology Market

• 29.1. Africa Veterinary Oncology Market Overview
• 29.2. Africa Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Veterinary Oncology Market Competitive Landscape And Company Profiles

• 30.1. Veterinary Oncology Market Competitive Landscape
• 30.2. Veterinary Oncology Market Company Profiles
  • 30.2.1. PetCure Oncology Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Zoetis Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Karyopharm Therapeutics Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Varian Medical Systems Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Accuray Incorporated
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Veterinary Oncology Market Competitive Benchmarking

32. Global Veterinary Oncology Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Veterinary Oncology Market

34. Veterinary Oncology Market Future Outlook and Potential Analysis

• 34.1 Veterinary Oncology Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Veterinary Oncology Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Veterinary Oncology Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer